Day One Biopharmaceuticals公布2025年第四季度及全年财务业绩,并重申2026年展望与营收指引

美股速递
5 hours ago

Day One Biopharmaceuticals Inc.(简称:Day One)已正式披露其2025财年第四季度以及全年度的财务报告。与此同时,公司管理层重申了对2026财年的业务发展前景及既定的营业收入指引,展现出对未来业绩表现的坚定信心。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10